Director/PDMR Shareholding

/**/

RNS Number : 4937M GSK PLC 22 December 2025  

GSK plc (the 'Company') Transaction notification



1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Wendy Becker

b)

Position/status

Independent Non-Executive Director

c)

Initial notification/ amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GSK plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63

b)

Nature of the transaction

Purchase of 441 Ordinary Shares

c)

Price(s) and volume(s)



Price(s)

Volume(s)





£18.0909

441











d)

Aggregated information    

N/A (single transaction)

Aggregated volume Price



e)

Date of the transaction

2025-12-19

f)

Place of the transaction  

London Stock Exchange (XLON)



 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Elizabeth (Liz) McKee Anderson

b)

Position/status

Independent Non-Executive Director

c)

Initial notification/ amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GSK plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs') ISIN: US37733W2044

b)

Nature of the transaction

Purchase of 201 ADSs

c)

Price(s) and volume(s)



Price(s)

Volume(s)





$48.5550  

201











d)

Aggregated information    

N/A (single transaction)

Aggregated volume Price



e)

Date of the transaction

2025-12-19

f)

Place of the transaction  

New York Stock Exchange (XNYS)





1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Charles Bancroft

b)

Position/status

Senior Independent Non-Executive Director

c)

Initial notification/ amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GSK plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs') ISIN: US37733W2044

b)

Nature of the transaction

Purchase of 1,577 ADSs

c)

Price(s) and volume(s)



Price(s)

Volume(s)





$48.5550

1,577











d)

Aggregated information    

N/A (single transaction)

Aggregated volume Price



e)

Date of the transaction

2025-12-19

f)

Place of the transaction  

New York Stock Exchange (XNYS)



   

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr Anne Beal

b)

Position/status

Independent Non-Executive Director

c)

Initial notification/ amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GSK plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs') ISIN: US37733W2044

b)

Nature of the transaction

Purchase of 201 ADSs

c)

Price(s) and volume(s)



Price(s)

Volume(s)





$48.5550

201











d)

Aggregated information    

N/A (single transaction)

Aggregated volume Price



e)

Date of the transaction

2025-12-19

f)

Place of the transaction  

New York Stock Exchange (XNYS)



 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr Hal Dietz

b)

Position/status

Independent Non-Executive Director

c)

Initial notification/ amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GSK plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs') ISIN: US37733W2044

b)

Nature of the transaction

Purchase of 201 ADSs

c)

Price(s) and volume(s)



Price(s)

Volume(s)





$48.5550

201











d)

Aggregated information    

N/A (single transaction)

Aggregated volume Price



e)

Date of the transaction

2025-12-19

f)

Place of the transaction  

New York Stock Exchange (XNYS)





1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr Jeannie Lee

b)

Position/status

Independent Non-Executive Director

c)

Initial notification/ amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GSK plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs') ISIN: US37733W2044

b)

Nature of the transaction

Purchase of 202 ADSs

c)

Price(s) and volume(s)



Price(s)

Volume(s)





$48.5550

202











d)

Aggregated information    

N/A (single transaction)

Aggregated volume Price



e)

Date of the transaction

2025-12-19

f)

Place of the transaction  

New York Stock Exchange (XNYS)





1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr Vishal Sikka

b)

Position/status

Independent Non-Executive Director

c)

Initial notification/ amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GSK plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs') ISIN: US37733W2044

b)

Nature of the transaction

Purchase of 730 ADSs

c)

Price(s) and volume(s)



Price(s)

Volume(s)





$48.5550

730











d)

Aggregated information    

N/A (single transaction)

Aggregated volume Price



e)

Date of the transaction

2025-12-19

f)

Place of the transaction  

New York Stock Exchange (XNYS)





1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Lady Susan Symonds

b)

Position/status

PCA of Sir Jonathan Symonds (Non-Executive Chair)

c)

Initial notification/ amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GSK plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63

b)

Nature of the transaction

Purchase of 1,650 Ordinary Shares

c)

Price(s) and volume(s)



Price(s)

Volume(s)





£18.1046

1,650











d)

Aggregated information    

N/A (single transaction)

Aggregated volume Price



e)

Date of the transaction

2025-12-22

f)

Place of the transaction  

London Stock Exchange (XLON)

  About GSK GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.   Registered in England & Wales: No. 3888792   Registered Office: 79 New Oxford Street London WC1A 1DG

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  DSHFEDFFEEISEEE